Efti plus Keytruda and chemo achieved a 61% response rate in first-line advanced non-squamous non–small cell lung cancer, ...

Novel combination achieves 60.8% response rate and 90.2% disease control rate in first-line non-small cell lung cancer (1L ...

With lung tumour cases on the rise in India, robotic-assisted thoracic surgery offers a breakthrough—providing faster ...

The presentation titled " Utilization of Proteomic Testing in Pulmonary Nodule Risk Stratification at a Safety-Net Hospital: ...

Amplia Therapeutics and Immutep have released clinical trial results that promise more effective treatments for pancreatic ...

Cancer survivor Cori Casebeer of Redding holds a sign supporting cancer research during the Hands Off! rally on April 5, 2025 ...

Higher-than-usual doses of radiation in the treatment of inoperable lung cancer can be safely combined with immunotherapy ...

The OSF Healthcare Cancer Institute in Peoria is now offering better information to detect lung cancer faster.

The Gazette will host a series of free, virtual panel discussions this week aimed at exploring Iowa's cancer rates, the ...

Investigators are using MET immunohistochemistry testing and FDA-approved profiling tools to personalize care and address ...

In the POTOMAC study, one year of treatment with Imfinzi (durvalumab) plus standard-of-care BCG induction and maintenance ...

There's no exact cause known for the rise in cancers among young people, according to experts, but researchers are trying to ...